A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration

Abstract Growing evidence has demonstrated the association between necroptosis and tumorigenesis and immunotherapy. However, the influence of overall necroptosis related genes on prognosis and immune microenvironment of breast cancer is still unclear. In this study, We systematically analyzed the ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Dezhi Lu, Sifang Qiu, Zhiqiang Zeng
Format: Article
Language:English
Published: Springer 2025-01-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-01770-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544559066087424
author Dezhi Lu
Sifang Qiu
Zhiqiang Zeng
author_facet Dezhi Lu
Sifang Qiu
Zhiqiang Zeng
author_sort Dezhi Lu
collection DOAJ
description Abstract Growing evidence has demonstrated the association between necroptosis and tumorigenesis and immunotherapy. However, the influence of overall necroptosis related genes on prognosis and immune microenvironment of breast cancer is still unclear. In this study, We systematically analyzed the necroptosis related gene patterns and tumor microenvironment characteristics of 1294 breast cancer patients by clustering the gene expression of 22 necroptosis related genes. Three breast cancer subtypes that had different necroptosis patterns and distinct tumor microenvironment characteristics were recognized. The NecroptosisCluster B was featured by favorable prognosis, activated immune molecules and higher scores of immune cells. The NecroptosisScore was constructed to quantitatively evaluate the necroptosis level of individual patients. High NecroptosisScore were characterized by elevated expression levels of MHC molecules, stimulated infiltration of immune cells and lengthened survival. High NecroptosisScore were correlated with lower tumor mutation burden (TMB), and higher PD-1/CTLA4 expression. Surprisingly, patients with high NecroptosisScore exhibited better benefits in immunotherapy. This study highlighted that necroptosis was correlated with several aspects of breast cancer and affected the immune function. Further understanding of necroptosis will support our insight into the tumor immune landscape of breast cancer and facilitate the development of more effective treatment strategies.
format Article
id doaj-art-ffda1e37ed98401693f0bdeabd702129
institution Kabale University
issn 2730-6011
language English
publishDate 2025-01-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-ffda1e37ed98401693f0bdeabd7021292025-01-12T12:29:08ZengSpringerDiscover Oncology2730-60112025-01-0116111610.1007/s12672-025-01770-6A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltrationDezhi Lu0Sifang Qiu1Zhiqiang Zeng2Department of Breast, Foshan Fosun Chancheng HospitalDepartment of Gastroenterology, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s HospitalDepartment of Breast, Foshan Fosun Chancheng HospitalAbstract Growing evidence has demonstrated the association between necroptosis and tumorigenesis and immunotherapy. However, the influence of overall necroptosis related genes on prognosis and immune microenvironment of breast cancer is still unclear. In this study, We systematically analyzed the necroptosis related gene patterns and tumor microenvironment characteristics of 1294 breast cancer patients by clustering the gene expression of 22 necroptosis related genes. Three breast cancer subtypes that had different necroptosis patterns and distinct tumor microenvironment characteristics were recognized. The NecroptosisCluster B was featured by favorable prognosis, activated immune molecules and higher scores of immune cells. The NecroptosisScore was constructed to quantitatively evaluate the necroptosis level of individual patients. High NecroptosisScore were characterized by elevated expression levels of MHC molecules, stimulated infiltration of immune cells and lengthened survival. High NecroptosisScore were correlated with lower tumor mutation burden (TMB), and higher PD-1/CTLA4 expression. Surprisingly, patients with high NecroptosisScore exhibited better benefits in immunotherapy. This study highlighted that necroptosis was correlated with several aspects of breast cancer and affected the immune function. Further understanding of necroptosis will support our insight into the tumor immune landscape of breast cancer and facilitate the development of more effective treatment strategies.https://doi.org/10.1007/s12672-025-01770-6NecroptosisBreast cancerPrognosisTumor microenvironmentImmune cell infiltrationImmunotherapy
spellingShingle Dezhi Lu
Sifang Qiu
Zhiqiang Zeng
A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
Discover Oncology
Necroptosis
Breast cancer
Prognosis
Tumor microenvironment
Immune cell infiltration
Immunotherapy
title A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
title_full A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
title_fullStr A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
title_full_unstemmed A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
title_short A novel necroptosis-related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
title_sort novel necroptosis related gene signature predicts the prognosis and immunotherapeutic response in breast cancer through immune infiltration
topic Necroptosis
Breast cancer
Prognosis
Tumor microenvironment
Immune cell infiltration
Immunotherapy
url https://doi.org/10.1007/s12672-025-01770-6
work_keys_str_mv AT dezhilu anovelnecroptosisrelatedgenesignaturepredictstheprognosisandimmunotherapeuticresponseinbreastcancerthroughimmuneinfiltration
AT sifangqiu anovelnecroptosisrelatedgenesignaturepredictstheprognosisandimmunotherapeuticresponseinbreastcancerthroughimmuneinfiltration
AT zhiqiangzeng anovelnecroptosisrelatedgenesignaturepredictstheprognosisandimmunotherapeuticresponseinbreastcancerthroughimmuneinfiltration
AT dezhilu novelnecroptosisrelatedgenesignaturepredictstheprognosisandimmunotherapeuticresponseinbreastcancerthroughimmuneinfiltration
AT sifangqiu novelnecroptosisrelatedgenesignaturepredictstheprognosisandimmunotherapeuticresponseinbreastcancerthroughimmuneinfiltration
AT zhiqiangzeng novelnecroptosisrelatedgenesignaturepredictstheprognosisandimmunotherapeuticresponseinbreastcancerthroughimmuneinfiltration